Administration route |
intravenous infusion |
Dosage |
600 mg, three loading doses within a 9-day period, then 600 mg on Days 1, 8, 15 and 22 ofEach 28-day cycle |
Pts |
66 |
Age |
Adult, Older_Adult |
Outcome |
0/66(CR); 18/66(PR) |
Adverse reactions |
64/64(Blood and lymphatic system disorders; Cardiac disorders; Gastrointestinal disorders; General disorders; Hepatobiliary disorders; Hepatobiliary disorders; Infections and infestations; Metabolism and nutrition disorders; Nervous system disorders; Renal and urinary disorders; Respiratory, thoracic and mediastinal disorders; Skin and subcutaneous tissue disorders; Vascular disorders) |
References |
PMID:
28935773
|
|